Joanna Perry MNZM has been appointed to the Board of Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company.
The Chartered Accountant Fellow joins as an Independent Director and will Chair the Board’s Audit Finance Committee.
The appointment of Ms Perry comes as the 100% New Zealand-owned private company prepares to enter both domestic and international markets.
“Joanna’s significant governance experience, combined with her well-known inquisitive probing, will be a real asset. Her nature to challenge and always seek continuous improvement strongly aligns with Helius’ internal cultural value of staying curious,” says Carmen Doran, Chief Executive of Helius Therapeutics.
Press Release – Helius Therapeutics
Joanna Perry MNZM has been appointed to the Board of Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company.
New Helius board member, Joanna Perry MNZM.
The Chartered Accountant Fellow joins as an Independent Director and will Chair the Board’s Audit Finance Committee.
The appointment of Ms Perry comes as the 100% New Zealand-owned private company prepares to enter both domestic and international markets.
“Joanna’s significant governance experience, combined with her well-known inquisitive probing, will be a real asset. Her nature to challenge and always seek continuous improvement strongly aligns with Helius’ internal cultural value of staying curious,” says Carmen Doran, Chief Executive of Helius Therapeutics.